Schurter ramps up component production in pandemic response

Electronics and components company Schurter has ramped up the production of its medical products to assist in the battle against COVID-19.

The new Coronavirus SARS-CoV-2 has been raging since January 2020, spreading at an unprecedented pace, exhibiting insidious properties and puzzling experts, which Schurter took into account.

Thanks to expertise in manufacturing as a supplier of medical technology, Schurter was able to avert the lockdown of many of its production facilities. Pandemic and system-relevant plants were closed in very few countries.

Schurter took advantage of this situation and decided to drastically increase its capacities in favour of the production of components and input systems for medical technology.